Eribulin Mesylate 0.88 Mg · Vial

Epbriv 0.88毫克注射液

Rx (Prescription Medicine)

USD $ 120.00

上传处方 Ask about this medicine
  • 由持牌药房合作伙伴发货
  • 全球可追踪配送
  • Secure payment

关键信息

活性成分
Eribulin Mesylate
规格
0.88 Mg
剂型
Injection
药物类别
Generic
品牌
Epbriv
生产厂家
Hetero Healthcare
包装规格
1 Vial

描述

Epbriv 0.88mg 注射剂是一种处方药,用于特定神经系统疾病的管理。Epbriv 中的活性成分可能是一种旨在靶向并调节中枢神经系统中神经递质活性或其他通路的成分。通过注射给药,表明需要快速或精确地输送活性成分。Epbriv 适用于其特定作用机制能够提供治疗益处的情况,例如某些类型的癫痫或其他需要仔细控制症状的神经系统疾病。Epbriv 0.88mg 注射剂的用药量和给药方式应严格遵循合格医疗专业人员提供的指示。常见不良反应可能包括但不限于头晕、疲劳、头痛或注射部位反应。患者应向医生报告任何持续或严重的不良反应。Epbriv 0.88mg 注射剂应储存在室温下,避免直接光照和潮湿,并放在儿童不易触及的地方。

其他信息

Medicine Form
Rx Status
Medicine Type
Molecule
Strength
本页内容
  1. 关键信息
  2. 描述
  3. 其他信息

内容完整性

医学审核

Renu Meena, B.Pharm

Medical Content Writer

Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.

最后审核 27/08/2026

运送至您的国家

Options
Fast Delivery – Arrives in 7–12 Days, Express shipping (Arriving in 3-7 days )
Free over
USD $ 200.00